You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial

Naoki Ito, Hitomi Saito, Shinobu Seki, Fumitaka Ueda and Takashi Asada

[Journal of Alzheimer’s Disease, 62(4)2018, 1767-1775, DOI 10.3233/JAD-170969]

On page 1769, left column, line 8, the following method of patient allocation is incorrectly given: “participants were assigned to the AS or placebo group using an alternating quasi-randomization allocation method.”

However, the following method was actually used: “non-alternating quasi-randomization allocation method”. With this method the controller, other researchers, and physicians do not know which group the next participants would be assigned to.